mHealth Medication Safety Intervention
Completed · Not applicable
Conditions studied: Medication Compliance
In brief
TRANSAFE Rx is a 12-month, parallel two-arm, 1:1 randomized controlled clinical trial, involving 136 participants (68 in each arm) measuring the clinical and economic effectiveness of a pharmacist-led intervention, which utilizes an innovative mHealth application to improve medication safety and health outcomes, as compared to usual post-transplant care. The primary goal of the TRANSAFE Rx study is to demonstrate significant reductions in med safety issues leading to reduced healthcare resource utilization in kidney transplantation through a pharmacist-led, mHealth-enabled, intervention. This study will provide detailed and novel information on the incidence, etiologies and outcomes of med errors and adverse drug events in this high-risk population; while also demonstrating the effectiveness of this intervention on reducing the incidence and impact of med safety issues in kidney transplantation.
Key facts
- Study ID
- NCT03247322
- Run by
- Medical University of South Carolina
- People needed
- 136
- Starts
- 2017-10-11
- Expected to finish
- 2020-05-30
- Last updated by the study team
- 2021-02-25
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Kidney transplant recipient between 6 and 36 months post-transplant
- At least 18 years of age
- Transplant MD agrees that patient is eligible to participate
You may not qualify if…
- Multi-organ recipient
- Patient is incapable of:
- Measuring their own blood pressure and glucose (if applicable)
- Self-administering medications
- Speaking, hearing and reading English
- Utilizing the mHealth application, after training
Where it is running
- Medical University of South Carolina — Charleston, South Carolina, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.